Immunovant (IMVT)
(Delayed Data from NSDQ)
$15.40 USD
+0.29 (1.92%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $15.44 +0.04 (0.26%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Immunovant, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IMVT 15.40 +0.29(1.92%)
Will IMVT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IMVT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMVT
Immunovant (IMVT) Up 7.8% Since Last Earnings Report: Can It Continue?
IMVT Stock Up 11% on Upbeat Batoclimab Hyperthyroidism Study Results
IMVT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Immunovant's Q1 Loss Narrower Than Expected, Pipeline in Focus
All You Need to Know About Immunovant (IMVT) Rating Upgrade to Buy
Wall Street Analysts See a 137.68% Upside in Immunovant (IMVT): Can the Stock Really Move This High?
Other News for IMVT
Is IMVT building bearish momentum? 20 Day Moving Average Resistance shows up after declining 1.18%
IMVT forms 20 Day Moving Average Resistance on September 16
Is IMVT primed for downward momentum? Fell Below 20 Day Moving Average shows up after sinking 3.9%
Tracking Baker Brothers Portfolio - Q2 2025 Update
IMVT Fell Below 50 Day Moving Average on September 12